{
    "eid": "2-s2.0-84992028979",
    "title": "Guidelines to improve urticarial care and the remaining research gaps",
    "cover-date": "2016-09-01",
    "subject-areas": [
        {
            "$": "Immunology and Allergy",
            "@code": "2723"
        },
        {
            "$": "Immunology",
            "@code": "2403"
        }
    ],
    "keywords": [],
    "authors": [
        "Kiat Ruxrungtham"
    ],
    "citedby-count": 2,
    "ref-count": 11,
    "ref-list": [
        "BSACI guideline for the management of chronic urticaria and angioedema",
        null,
        "Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines",
        "Clinical practice guideline for diagnosis and management of urticaria",
        "Clinical features of chronic urticaria in aging population",
        "Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: A multi-centre, double-blind, randomized, placebo-controlled study",
        "Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients",
        "Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled, parallel, multicenter study",
        "Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on h 1 antihistamines: A randomized, placebo-controlled study",
        "The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria",
        null
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}